Product
Hepatitis A Vaccine
1 clinical trial
1 indication
Indication
Hepatitis AClinical trial
Open Label Study to Assess the ~32-Year Persistence of Hepatitis A Antibody Among Participants in the Pivotal, Double-Blind, Placebo-Controlled Efficacy Study of VAQTA (Study 023-001)Status: Not yet recruiting, Estimated PCD: 2025-03-01